| Today, Fri, Dec 18, 2009 | | • | Taro Announces Clinical Trials with T2007, Its Second Proprietary Non-Sedating Barbiturate Drug
Business Wire (Fri 4:49pm)
| | Thu, Dec 10, 2009 | | • | Taro Sends Important Update to Shareholders
Business Wire (Thu, Dec 10)
| | Tue, Dec 8, 2009 | | • | Taro Sends Letter to Update Shareholders
Business Wire (Tue, Dec 8)
| | Fri, Dec 4, 2009 | | • | FDA Approves Initiation of Clinical Studies in the U.S. for T2000, Taro's Proprietary Non-Sedating Barbiturate Compound
Business Wire (Fri, Dec 4)
| | Wed, Dec 2, 2009 | | • | Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Business Wire (Wed, Dec 2)
| | Tue, Sep 29, 2009 | | • | Taro Files Lawsuit Against Sun in U.S. Federal Court
GlobeNewswire (Tue, Sep 29)
| | Mon, Jul 27, 2009 | | • | Taro Sues Synerx Pharma, Karalex Pharma and DPT Laboratories for Patent Infringement
GlobeNewswire (Mon, Jul 27)
| | Thu, Jun 11, 2009 | | • | Taro Announces Preliminary Court Approval of Settlement in Securities Lawsuit
GlobeNewswire (Thu, Jun 11)
| | Fri, May 22, 2009 | | • | Taro Provides Preliminary First Quarter 2009 Financial Results
GlobeNewswire (Fri, May 22)
| | • | Taro to Restate Financial Results for 2004 and 2005; Revises 2006, 2007 and 2008 Estimated Financial Results
GlobeNewswire (Fri, May 22)
| | Thu, May 21, 2009 | | • | Taro Receives FDA Approval for Sulfacetamide Sodium Topical Suspension ANDA
GlobeNewswire (Thu, May 21)
|
Add TAROF.PK News to My Yahoo!:
 
| |
|
0.20% Nasdaq 
Headlines
